Lawyer profile
Torrey Cope
Sidley
- Firm
- Sidley
- Practice
- FDA Regulatory, Food, Drug and Medical Device
- Office
- Washington, D.C.
- Active in the record
- 2023 to 2026
Deal experience
Sectors
Jurisdictions
Deals
7 announced deals in the record Sidley Represents Werewolf Therapeutics in Merger with Ambros Therapeutics and Concurrent US$150 Million Private Placement 24 Aug 2026
Sidley Represents Bio-Techne in Its US$11.3 Billion Acquisition by Merck KGaA 1 Jul 2026
Sidley Represents Changchun GeneScience (GenSci) Pharmaceuticals in Its Strategic Licensing Agreement With Yarrow Bioscience for First-in-Class Autoimmune Thyroid Disease Therapy 19 Dec 2025
Sidley Represents Immunovant in US$550 Million Offering 16 Dec 2025
Sidley Represents Nuvalent in Pricing of US$500 Million Public Offering 21 Nov 2025
Sidley Represents Capricor Therapeutics in US$23 Million Common Stock Offering 4 Oct 2023
Sidley Represents Atia Vision Inc. in Series E Financing 14 Apr 2023
Deal alerts PRO
Get an email when Torrey Cope is named on a newly announced deal.
Alerts come as one daily email at most.
Analytics
Based on announced deals in DealDatabaseLoading analytics…
Complete deal history
Is this you?
Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.
Claim this profile